As HHS Head, RFK Jr. Has Potential to be Trump’s Most Successful Agent for Change
As Professor Jacobson and Kemberlee Kaye noted in their most recent podcast, President-elect Donald Trump has rapidly named many nominees to significant positions in his new administration.
One aspect of this speed-signaling that I view as positive is that when Trump won the 2016 election, it took him some time to name a single candidate. Then, his first choice was Jeff Sessions for Attorney General, who was tapped to help Trump navigate policies successfully through the bureaucratic swaps.
As a reminder: Sessions resigned after meekly allowing Robert Mueller to begin a disgraceful, hoax-based Russian collusion investigation after recusing himself from the matter.
Clearly, Trump is using a different template this time. He is done building bridges and now intends to take a bulldozer through the Swamp.
At first glance, he is selecting experienced people targeted or otherwise negatively impacted by the agency Trump wants them to head. And this observation brings be to my analysis of Trump’s selection of Robert F. Kennedy, Jr. as the head of Health and Human Services, which includes the agencies I often cover: The Food and Drug Administration (FDA), the Centers for Disease Control and Prevention (CDC) and the National Institutes of Health (NIH).
I would like to use the Wayback Machine and cite the review I did of Robert F. Kennedy, Jr.’s book: The Real Dr. Fauci.
I usually like to quote a specific passage of the book, but I found myself highlighting so many worthwhile sections and paragraphs, that I would like to condense perhaps the most important take-away from The Real Anthony Fauci: The template for the response to COVID-19 can be found by reviewing how Fauci took over billions of government dollars and dominated the sister agencies associated with NIAID (e.g., Food and Drug Administration, Centers for Disease Control and Prevention, and Health and Human Services) with the advent of the Human Immunodeficiency Virus/Acquired Immunodeficiency Syndrome (HIV/AIDS) epidemic.On page 172, Kennedy consolidates Fauci’s activities during the 1980’s to summarize the Big Pharma/Vaccine-centric approach that evolved as the NIAID empire grew. Some of the highlights on a chilling and very comprehensive list on Fauci’s AIDS-response that should be quite familiar to us all at this point:
- pumping up pandemic fears to lay the groundwork for larger budgets and greater powers.
- periodically stoking waning fear levels by warning of mutant super-strains and future surges
- suggesting substantial changes to how people live, ostensibly to save lives
- ignoring and dismissing off-the-shelf therapeutic remedies
- promising ultimate salvation with vaccines
Kennedy has an in-depth knowledge of the labyrinth of connections between Big Pharma and government bureaucrats. He is in the position to be the most effective agent for change in the Trump administration.
Upon reflection, one of the most significant issues I had with Trump was how “two weeks to slow the spread” morphed into a multi-year pandemic lockdown extravaganza. This occurred because Fauci and his fellow COVID advisor, Dr. Deborah Birx, used the bureaucratic state to enforce poor policy and countermand Trump’s reopen orders.
I view the appointment of Kennedy as Trump’s way of apologizing to the nation for what occurred in 2020. Whatever your feelings about Kennedy’s positions on vaccines, you can be sure he will never allow anyone like Fauci or Birx to impact the nation at that scale again.
The HHS appointment may be Trump’s gift to Kennedy, for stepping aside and directing the Make American Healthy Again (MAHA) supporters to vote for the GOP ticket instead. This move was one of the most pivotal moments in the victorious presidential campaign, which was struggling in the wake of Harris’ installment.
But this appointment may also turn out to be a gift for the American people. Kennedy promises that much of his effort will go into addressing the significant epidemic of chronic diseases in this country, which is having a profound impact on public health, healthcare costs, and overall life expectancy.
Chronic disease accounts for 5 of the top 10 leading causes of death in the US. Approximately 90% of the annual $4.1 trillion healthcare expenditure is attributed to medical care for such illnesses. Determining the factors contributing to this problem, then informing the public would greatly help Americans as well as the economy.
For this reason, Kennedy’s support is bipartisan. Colorado Governor Jared Polis (D) stated that Kennedy “helped us defeat vaccine mandates in Colorado in 2019 and will help make America healthy again by shaking up HHS and FDA.”
Admittedly, many have issues with Kennedy’s opinions on specific topics (i.e., linking vaccines to autism). However, to be fair, we have seen how much science data and discussion that counters the preferred narratives has been defunded, deleted, or shadow-banned.
Finally, Biden’s head of HHS is Xavier Becerra. Becerra’s qualifications to run HHS were cosponsoring the Affordable Care Act as a California congressman and leasing multistate lawsuits to defend it as the state Attorney General.
I would argue Kennedy is more qualified for the appointment than Becerra was.
One last data point to conclude this analysis of Trump’s pick for HHS:
For all these reasons, I am fine with Kennedy heading this agency and I am bracing myself for the inevitable trotting out of “experts” and fear-mongering from our propaganda media that ensues whenever a real agent of change is installed.
If Kennedy does nothing more than cut the binds between Big Pharma, Big Government, and Big Media, he will be known as one of the most effective administrators in American history.
CLICK HERE FOR FULL VERSION OF THIS STORY